Fuad El-Hibri (Evy Mages/The Washington Post via Getty Images)
May 2, 2022 08:38 AM EDTUpdated 09:23 AM
People
Pharma
Manufacturing

Just weeks af­ter he stepped down as chair­man, Emer­gen­t's for­mer CEO dies at age 64

Josh Sullivan

In the 20-plus years of his com­pa­ny’s ex­is­tence, Fuad El-Hi­b­ri built up a man­u­fac­tur­ing con­stant that gained the trust of the US gov­ern­ment with just …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

Pfiz­er shares new de­tails on obe­si­ty pipeline, hints at ‘oth­er op­por­tu­ni­ties’

GSK buys au­toim­mune T cell en­gager for $300M up­front from Chim­a­gen

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

Fol­low­ing March in­spec­tion, No­vo Nordisk's semaglu­tide man­u­fac­tur­ing fa­cil­i­ty cit­ed by FDA

A service from the Financial Times